HIV drug resistance in adults receiving early versus delayed antiretroviral therapy: HPTN 052

INTRODUCTION: We evaluated HIV drug resistance in adults who received early versus delayed antiretroviral therapy (ART) in a multi-national trial (HPTN 052, enrollment 2005–2010). In HPTN 052, 1,763 index participants were randomized to start ART at a CD4 cell count of 350–550 cells/mm(3) (early ART...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Acquir Immune Defic Syndr
Glavni autori: Palumbo, Philip J., Fogel, Jessica M., Hudelson, Sarah E., Wilson, Ethan A., Hart, Stephen, Hovind, Laura, Piwowar-Manning, Estelle, Wallis, Carole, Papathanasopoulos, Maria A., Morgado, Mariza G., Saravanan, Shanmugam, Tripathy, Srikanth, Eron, Joseph J., Gallant, Joel E., McCauley, Marybeth, Gamble, Theresa, Hosseinipour, Mina C., Kumarasamy, Nagalingeswaran, Hakim, James G., Pilotto, Jose H., Kumwenda, Johnstone, Akelo, Victor, Godbole, Sheela V., Santos, Breno R., Grinsztejn, Beatriz, Panchia, Ravindre, Chariyalertsak, Suwat, Makhema, Joseph, Badal-Faesen, Sharlaa, Chen, Ying Q., Cohen, Myron S., Eshleman, Susan H.
Format: Artigo
Jezik:Inglês
Izdano: 2018
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5844834/
https://ncbi.nlm.nih.gov/pubmed/29293156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000001623
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items